ERp19 contributes to tumorigenicity in human gastric cancer by promoting cell growth, migration and invasion.
ERp19 contributes to tumorigenicity in human gastric cancer by promoting cell growth, migration and invasion.
复制标题
ERp19 通过促进细胞生长、迁移和侵袭而导致人胃癌的致瘤性
DOI：
10.18632/oncotarget.3649
复制
发表时间：
2015-05-20
期刊：
影响因子：
--
通讯作者：
Xu CD
中科院分区：
文献类型：
--
作者：
Wu J;Chen XH;Wang XQ;Yu Y;Ren JM;Xiao Y;Zhou T;Li P;Xu CD
ERp19 是一种哺乳动物硫氧还蛋白样蛋白，在防御内质网应激中发挥着关键作用。它属于蛋白质二硫键异构化 (PDI) 家族，该家族成员与乳腺癌、卵巢癌和胃肠道癌症的发生有关。然而，ERp19 在胃癌 (GC) 中的作用仍不清楚。因此，我们试图研究ERp19在GC患者中的表达和预后价值，并探讨ERp19在致瘤性中的作用。通过免疫组织化学染色和实时 PCR 评估 GC 患者临床样本中胃组织中 ERp19 的表达。临床病例统计分析显示，肿瘤组织中ERp19的表达水平高于非肿瘤组织。 ERp19表达水平与肿瘤大小、淋巴结受累及不良临床预后相关。此外，ERp19敲低显着抑制胃癌细胞生长，抑制细胞迁移/侵袭并下调FAK和桩蛋白的磷酸化，而ERp19过表达则逆转了这些变化。我们得出结论，ERp19通过激活FAK信号通路促进GC的致瘤性和转移，并且可能作为GC的癌基因。 ERp19可能代表一种新的诊断和预后标志物以及GC治疗的新靶点。
ERp19, a mammalian thioredoxin-like protein, plays a key role in defense against endoplasmic reticulum stress. It belongs to the protein disulfide isomerize (PDI) family, whose members have been implicated in development of breast, ovarian and gastrointestinal cancers. However, the role of ERp19 in gastric cancer (GC) remains undefined. Therefore, we sought to investigate the expression and prognostic value of ERp19 in GC patients, and to explore the role of ERp19 in tumorigenicity. Expression of ERp19 in gastric tissues was assessed by immunohistochemical staining and real-time PCR in clinical samples of GC patients. Statistical analysis of clinical cases revealed that the expression levels of ERp19 were higher in tumor tissues than non-tumor tissues. And the level of ERp19 expression was correlated with tumor size, lymph node involvement and poor clinical prognosis. Furthermore, ERp19 knockdown dramatically suppressed gastric cancer cell growth, inhibited cellular migration/invasion and down-regulated the phosphorylation of FAK and paxillin, whereas ERp19 over-expression reversed these changes. We conclude that ERp19 contributes to tumorigenicity and metastasis of GC by activating the FAK signaling pathway, and may function as an oncogene in GC. ERp19 may represent a new diagnostic and prognostic marker and a novel target for the treatment of GC.
登录
查看更多内容
影响因子：
5.7
作者：
Bid HK;Roberts RD;Manchanda PK;Houghton PJ
通讯作者：
Houghton PJ
影响因子：
6.4
作者：
Grisaru-Granovsky, S;Salah, Z;Bar-Shavit, R
通讯作者：
Bar-Shavit, R
影响因子：
3.8
作者：
Leys, Charles M.;Nomura, Sachiyo;Goldenring, James R.
通讯作者：
Goldenring, James R.
人蛋白二硫化物异构酶基因家族。
影响因子：
4.5
作者：
Galligan JJ;Petersen DR
通讯作者：
Petersen DR
影响因子：
64.8
作者：
Compagno, Mara;Lim, Wei Keat;Grunn, Adina;Nandula, Subhadra V.;Brahmachary, Manisha;Shen, Qiong;Bertoni, Francesco;Ponzoni, Maurilio;Scandurra, Marta;Califano, Andrea;Bhagat, Govind;Chadburn, Amy;Dalla-Favera, Riccardo;Pasqualucci, Laura
通讯作者：
Pasqualucci, Laura